Church & Dwight vs Kenvue
Side-by-side comparison of AI visibility scores, market position, and capabilities
Consumer goods company with $6B revenue; Arm & Hammer, OxiClean, Trojan, and Waterpik portfolio targeting mid-tier value-oriented consumers competing with P&G and Colgate-Palmolive.
About
Church & Dwight is a consumer packaged goods company producing personal care, household, and specialty products across well-known brands including Arm & Hammer (baking soda-based cleaning and dental products), OxiClean (laundry stain remover), Trojan condoms, Vitafusion gummies vitamins, Waterpik water flosser, Batiste dry shampoo, and Zicam cold remedies. Listed on NYSE (NYSE: CHD) and headquartered in Ewing, New Jersey, Church & Dwight generates approximately $6 billion in annual revenue and has demonstrated consistent organic growth through its "power brand" portfolio management strategy.\n\nChurch & Dwight's brand portfolio spans multiple consumer need categories: Arm & Hammer (baking soda as a platform for toothpaste, cat litter, laundry detergent, and odor eliminator), personal care (Waterpik, Batiste dry shampoo, XTRA laundry), vitamins (Vitafusion and L'il Critters gummy vitamins), sexual health (Trojan, Natalist fertility), and household products (OxiClean, Kaboom). The Arm & Hammer baking soda brand's versatility across multiple product categories creates unique brand leverage.\n\nIn 2025, Church & Dwight has been one of the more consistent performers in consumer staples — the company targets value-oriented consumers in mid-tier price positions (above private label, below premium brands) across its categories. It competes with Procter & Gamble, Colgate-Palmolive, and Henkel for household and personal care market share. The company's 2025 strategy focuses on expanding its international distribution (historically US-focused, with international growth potential for brands like Batiste and Waterpik), growing Vitafusion in the wellness supplement category, and pursuing selective brand acquisitions in premium personal care niches.
Skillman NJ consumer health (NYSE: KVUE) ~$15.5B FY2024 revenue; J&J spinoff May 2023, Tylenol/Band-Aid/Neutrogena/Listerine/Aveeno portfolio, talc litigation exposure competing with Haleon and P&G.
About
Kenvue Inc. is a Skillman, New Jersey-based consumer health company — publicly traded on the New York Stock Exchange (NYSE: KVUE) as an S&P 500 Consumer Staples component — marketing and selling over-the-counter medicines, skin health and beauty products, and essential health products through iconic consumer brands including Tylenol (pain and fever relief), Band-Aid (wound care), Neutrogena (skin care), Johnson's (baby care), Listerine (oral care), Aveeno (skincare), Motrin/Advil (ibuprofen pain relief), Zyrtec (allergy), Nicorette (smoking cessation), Neosporin (antibiotic ointment), and Benadryl through approximately 22,000 employees in 165 countries. Kenvue was separated from Johnson & Johnson through an IPO in May 2023 (the largest US IPO of 2023) and a tax-free distribution of J&J's remaining 89.6% stake to J&J shareholders in August 2023 — creating the world's largest pure-play consumer health company by market capitalization, with J&J retaining no ownership. In fiscal year 2024, Kenvue reported revenues of approximately $15.5 billion, with organic growth facing headwinds from lower cold/cough/flu season severity (Tylenol, Zyrtec, Benadryl volume sensitive to respiratory illness intensity), competitive pressure in skin health (Neutrogena competing with Korean beauty brands, Cerave, and pharmacy private label), and macroeconomic consumer trading down to lower-price alternatives in some markets. CEO Thibaut Mongon leads Kenvue's strategy of investing in the brand superiority of its household name portfolio while improving operational efficiency in the post-spinoff period (implementing Kenvue's own supply chain infrastructure, IT systems, and organizational structure previously shared with J&J).
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.